These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30688404)

  • 1. Phenyl and Diaryl Ureas with Thiazolo[5,4-d]pyrimidine Scaffold as Angiogenesis Inhibitors: Design, Synthesis and Biological Evaluation.
    Xue WJ; Deng YH; Yan ZH; Liu JP; Liu Y; Sun LP
    Chem Biodivers; 2019 Apr; 16(4):e1800493. PubMed ID: 30688404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and Synthesis of Novel Thiazolo[5,4-d]pyrimidine Derivatives as Potential Angiogenesis Inhibitors.
    Xue WJ; Du JY; Deng YH; Yan ZH; Liu JP; Liu Y; Sun LP
    Chem Biodivers; 2019 Aug; 16(8):e1900232. PubMed ID: 31287621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diarylureas and Diarylamides with Oxazolo[5,4-d]pyrimidine Scaffold as Angiogenesis Inhibitors.
    Deng YH; Liu JP; Cheng YJ; Liu Y; Sun LP
    Chem Biodivers; 2016 Sep; 13(9):1230-1239. PubMed ID: 27448711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyrimidinylacetamide-based 2-pyridylureas as Angiogenesis Inhibitors: Design, Synthesis and Biological Evaluation.
    Deng YH; Yan ZH; Liu JP; Liu Y; Sun LP
    Arch Med Res; 2017 May; 48(4):333-342. PubMed ID: 28882321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of novel DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitors: 3. Evaluation of 5-amino-linked thiazolo[5,4-d]pyrimidine and thiazolo[5,4-b]pyridine derivatives.
    Hirose M; Okaniwa M; Miyazaki T; Imada T; Ohashi T; Tanaka Y; Arita T; Yabuki M; Kawamoto T; Tsutsumi S; Sumita A; Takagi T; Sang BC; Yano J; Aertgeerts K; Yoshida S; Ishikawa T
    Bioorg Med Chem; 2012 Sep; 20(18):5600-15. PubMed ID: 22883026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration of carbamide derived pyrimidine-thioindole conjugates as potential VEGFR-2 inhibitors with anti-angiogenesis effect.
    Sana S; Reddy VG; Bhandari S; Reddy TS; Tokala R; Sakla AP; Bhargava SK; Shankaraiah N
    Eur J Med Chem; 2020 Aug; 200():112457. PubMed ID: 32422489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of tumor cell growth and angiogenesis by 7-aminoalkoxy-4-aryloxy-quinazoline ureas, a novel series of multi-tyrosine kinase inhibitors.
    Ravez S; Barczyk A; Six P; Cagnon A; Garofalo A; Goossens L; Depreux P
    Eur J Med Chem; 2014 May; 79():369-81. PubMed ID: 24747748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, antiangiogenesis evaluation and molecular docking studies of 1-aryl-3-[(thieno[3,2-b]pyridin-7-ylthio)phenyl]ureas: Discovery of a new substitution pattern for type II VEGFR-2 Tyr kinase inhibitors.
    Machado VA; Peixoto D; Costa R; Froufe HJ; Calhelha RC; Abreu RM; Ferreira IC; Soares R; Queiroz MJ
    Bioorg Med Chem; 2015 Oct; 23(19):6497-509. PubMed ID: 26344591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of 6-Arylurea-2-arylbenzoxazole and 6-Arylurea-2-arylbenzimidazole Derivatives as Angiogenesis Inhibitors: Design, Synthesis and in vitro Biological Evaluation.
    Zi M; Liu F; Wu D; Li K; Zhang D; Zhu C; Zhang Z; Li L; Zhang C; Xie M; Lin J; Zhang J; Jin Y
    ChemMedChem; 2019 Jul; 14(13):1291-1302. PubMed ID: 31131561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CPU-12, a novel synthesized oxazolo[5,4-d]pyrimidine derivative, showed superior anti-angiogenic activity.
    Liu J; Deng YH; Yang L; Chen Y; Lawali M; Sun LP; Liu Y
    J Pharmacol Sci; 2015 Sep; 129(1):9-17. PubMed ID: 26154846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, biological evaluation and dynamics simulation of indazole derivatives with antiangiogenic and antiproliferative anticancer activity.
    Elsayed NMY; Serya RAT; Tolba MF; Ahmed M; Barakat K; Abou El Ella DA; Abouzid KAM
    Bioorg Chem; 2019 Feb; 82():340-359. PubMed ID: 30428414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation of new pyrazolyl-ureas and imidazopyrazolecarboxamides able to interfere with MAPK and PI3K upstream signaling involved in the angiogenesis.
    Meta E; Brullo C; Sidibe A; Imhof BA; Bruno O
    Eur J Med Chem; 2017 Jun; 133():24-35. PubMed ID: 28371678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationship study of 2-(substituted benzylidene)-7-(4-fluorophenyl)-5-(furan-2-yl)-2H-thiazolo[3,2-a]pyrimidin-3(7H)-one derivatives as anticancer agents.
    Selvam TP; Karthick V; Kumar PV; Ali MA
    Drug Discov Ther; 2012 Aug; 6(4):198-204. PubMed ID: 23006990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinazoline-based multi-tyrosine kinase inhibitors: synthesis, modeling, antitumor and antiangiogenic properties.
    Conconi MT; Marzaro G; Urbani L; Zanusso I; Di Liddo R; Castagliuolo I; Brun P; Tonus F; Ferrarese A; Guiotto A; Chilin A
    Eur J Med Chem; 2013 Sep; 67():373-83. PubMed ID: 23900004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel tetrasubstituted 5-Arylamino pyrazoles able to interfere with angiogenesis and Ca
    Lusardi M; Belvedere R; Petrella A; Iervasi E; Ponassi M; Brullo C; Spallarossa A
    Eur J Med Chem; 2024 Oct; 276():116715. PubMed ID: 39083983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of angiogenesis involves in anticancer activity of riccardin D, a macrocyclic bisbibenzyl, in human lung carcinoma.
    Sun CC; Zhang YS; Xue X; Cheng YN; Liu HP; Zhao CR; Lou HX; Qu XJ
    Eur J Pharmacol; 2011 Sep; 667(1-3):136-43. PubMed ID: 21704029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and evaluation of novel thienopyrimidine-based agents bearing diaryl urea functionality as potential inhibitors of angiogenesis.
    Faraji A; Oghabi Bakhshaiesh T; Hasanvand Z; Motahari R; Nazeri E; Boshagh MA; Firoozpour L; Mehrabi H; Khalaj A; Esmaeili R; Foroumadi A
    Eur J Med Chem; 2021 Jan; 209():112942. PubMed ID: 33328104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of thiazolo[5,4-d]pyrimidine derivatives as potent antiproliferative agents through the drug repurposing strategy.
    Li ZH; Zhang J; Liu XQ; Geng PF; Ma JL; Wang B; Zhao TQ; Zhao B; Wei HM; Wang C; Fu DJ; Yu B; Liu HM
    Eur J Med Chem; 2017 Jul; 135():204-212. PubMed ID: 28456031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New 2,4-disubstituted-2-thiopyrimidines as VEGFR-2 inhibitors: Design, synthesis, and biological evaluation.
    Abdel-Mohsen HT; Girgis AS; Mahmoud AEE; Ali MM; El Diwani HI
    Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900089. PubMed ID: 31463965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and Biological Evaluation of Indole-2-carbohydrazide Derivatives as Anticancer Agents with Anti-angiogenic and Antiproliferative Activities.
    Zhang J; Liu T; Chen M; Liu F; Liu X; Zhang J; Lin J; Jin Y
    ChemMedChem; 2018 Jun; 13(12):1181-1192. PubMed ID: 29637713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.